Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasm Metastasis 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1

Interventions

Specimen Handling 5Nivolumab 5vorolanib 2pembrolizumab 2lenvatinib 2fludarabine 2cabozantinib 2anlotinib 2Sunitinib 2Nephrectomy 2Cyclophosphamide 2Biopsy 2Axitinib 2toripalimab 1tivozanib 1sintilimab 1pazopanib 1fludarabine phosphate 1enzalutamide 1cemiplimab 1bemarituzumab 1belzutifan 1balstilimab 1atezolizumab 1abiraterone 1Zoledronic Acid 1Saline Solution 1Rubidium-82 1Radiotherapy 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Renal Cell × Diphosphonates × Clear all
NCT07043608 2026-05-01

ZAMBONI

University of California, San Francisco

Phase 2 Not yet recruiting
20 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡